Journal Vaccine, published by STM publisher Elsevier, Netherlands, recently released a supplement dedicated to influenza vaccines. The publication, released during an influenza conference organised by the European Scientific Working Group on influenza (ESWI), provides a comprehensive overview on influenza vaccines and was supported by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).
The Vaccine supplement focuses entirely on new developments in the area of human influenza vaccines, by bringing together key experts from many of the relevant disciplines in this field. In their editorial, Marie Paule Kieny and Keiji Fukuda of the World Health Organization (WHO) specifically address the pandemic influenza vaccine challenge and stress that an efficient response at the outset of an influenza pandemic will depend on the robust global surveillance systems implemented by the WHO's Global Influenza Surveillance Network.
The 3rd European Influenza Conference in Portugal was organised by ESWI and had a scientific programme including every aspect of influenza prevention, control and treatment. Beyond the science, the conference also offered sessions and workshops for governmental representatives and opinion leaders in healthcare.
